Skip to main content

Table 2 Incidence of PONV and antiemetic treatment during the first 24 h after surgery

From: Comparison of postoperative nausea and vomiting between Remimazolam and Propofol in Patients undergoing oral and maxillofacial surgery: a prospective Randomized Controlled Trial

 

R group (n = 94)

P group (n = 95)

P-value

0–1 h

Nausea

6 (6.4%)

4 (4.2%)

0.536

Vomiting

1 (1.1%)

0 (0%)

0.497

PONV

6 (6.4%)

4 (4.2%)

0.536

Rescue antiemetics

6 (6.4%)

4 (4.2%)

0.536

1–6 h

Nausea

6 (6.4%)

6 (6.3%)

0.985

Vomiting

1 (1.1%)

1 (1.1%)

1.000

PONV

6 (6.4%)

6 (6.3%)

0.985

Rescue antiemetics

4 (4.3%)

5 (5.3%)

1.000

6–24 h

Nausea

1 (1.1%)

1 (1.1%)

1.000

Vomiting

0 (0%)

0 (0%)

-

PONV

1 (1.1%)

1 (1.1%)

1.000

Rescue antiemetics

0 (0%)

1 (1.1%)

1.000

0–24 h

Nausea

11 (11.7%)

10 (10.5%)

0.821

Vomiting

2 (2.1%)

1 (1.1%)

0.621

PONV

11 (11.7%)

10 (10.5%)

0.797

Rescue antiemetics

10 (10.6%)

10 (10.5%)

0.980

  1. Data are presented as number of patients (percentage). PONV postoperative nausea and vomiting